G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $103,453 | -44.9% | 38,602 | +11.6% | 0.00% | – |
Q4 2022 | $187,818 | – | 34,589 | +3458800.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
Q1 2022 | $168,000 | -22.9% | 22,129 | +3.5% | 0.00% | – |
Q4 2021 | $218,000 | -40.6% | 21,385 | -22.0% | 0.00% | – |
Q3 2021 | $367,000 | -18.1% | 27,412 | +34.5% | 0.00% | – |
Q2 2021 | $448,000 | -19.1% | 20,378 | -11.5% | 0.00% | – |
Q1 2021 | $554,000 | -57.1% | 23,022 | -68.0% | 0.00% | -100.0% |
Q4 2020 | $1,291,000 | +27.6% | 71,840 | -18.0% | 0.00% | 0.0% |
Q3 2020 | $1,012,000 | -8.5% | 87,660 | +92.2% | 0.00% | 0.0% |
Q2 2020 | $1,106,000 | +346.0% | 45,603 | +103.2% | 0.00% | – |
Q1 2020 | $248,000 | -66.6% | 22,444 | -20.0% | 0.00% | -100.0% |
Q4 2019 | $742,000 | +30.6% | 28,057 | +12.5% | 0.00% | – |
Q3 2019 | $568,000 | +6.8% | 24,949 | +43.7% | 0.00% | – |
Q2 2019 | $532,000 | +112.8% | 17,365 | +15.2% | 0.00% | – |
Q1 2019 | $250,000 | +14.2% | 15,075 | +31.3% | 0.00% | – |
Q4 2018 | $219,000 | -78.2% | 11,481 | -40.2% | 0.00% | -100.0% |
Q3 2018 | $1,004,000 | +34.9% | 19,189 | +12.1% | 0.00% | 0.0% |
Q2 2018 | $744,000 | +154.8% | 17,118 | +117.4% | 0.00% | – |
Q1 2018 | $292,000 | – | 7,874 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |